Cargando…
Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives
PURPOSE: Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers patients’ understanding of, and perspectives on, MS progression to better comprehend the unmet needs of people with MS (PwMS), in order to improve treatment adherence and quality of life (QoL). METHODS: L...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802794/ https://www.ncbi.nlm.nih.gov/pubmed/33447018 http://dx.doi.org/10.2147/PPA.S268829 |
_version_ | 1783635816741863424 |
---|---|
author | Celius, Elisabeth G Thompson, Heidi Pontaga, Maija Langdon, Dawn Laroni, Alice Potra, Stanca Bharadia, Trishna Yeandle, David Shanahan, Jane van Galen, Pieter Alexandri, Nektaria Kesselring, Jürg |
author_facet | Celius, Elisabeth G Thompson, Heidi Pontaga, Maija Langdon, Dawn Laroni, Alice Potra, Stanca Bharadia, Trishna Yeandle, David Shanahan, Jane van Galen, Pieter Alexandri, Nektaria Kesselring, Jürg |
author_sort | Celius, Elisabeth G |
collection | PubMed |
description | PURPOSE: Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers patients’ understanding of, and perspectives on, MS progression to better comprehend the unmet needs of people with MS (PwMS), in order to improve treatment adherence and quality of life (QoL). METHODS: Literature searches for peer-reviewed papers concerning patient perspectives on the progression of MS and comparable conditions, published between January 2000 and January 2020, were conducted. RESULTS: Little qualitative evidence exists that examines PwMS’ perspectives on MS progression. The understanding and meaning ascribed to terms such as “disease progression” vary. Some PwMS find disease labels stigmatizing, confusing, and disconnected from reality. The lack of a clear definition of progression and discrepancies between PwMS and healthcare professional (HCP) perspectives may contribute to misunderstanding and poor communication. Patient descriptions of progression and relapses include symptoms in addition to those evaluated by standard severity and disability measures. Compared with HCPs, PwMS are still focused on relapse prevention but place higher priority on QoL and ascribe different relative importance to the causes of poor adherence to treatment plans. PwMS want to discuss progression and likely prognosis. Such communication needs to be personalized and delivered with sensitivity, at an appropriate time. Poor treatment adherence may arise from a lack of understanding and poor communication, particularly around treatment goals. The few studies that directly considered patient perspectives on the progression of comparable conditions supported and extended the perspectives of PwMS. Lack of adequate communication by HCPs was the most common theme. CONCLUSION: Patient perspectives on disease progression in MS and other chronic progressive conditions are under-investigated and under-reported. The limited evidence available highlights the importance of providing adequate information and effective HCP communication. While further studies are needed, the current evidence base offers information and insights that may help HCPs to enhance patient care, well-being, and treatment adherence. |
format | Online Article Text |
id | pubmed-7802794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-78027942021-01-13 Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives Celius, Elisabeth G Thompson, Heidi Pontaga, Maija Langdon, Dawn Laroni, Alice Potra, Stanca Bharadia, Trishna Yeandle, David Shanahan, Jane van Galen, Pieter Alexandri, Nektaria Kesselring, Jürg Patient Prefer Adherence Review PURPOSE: Multiple sclerosis (MS) prognosis is often uncertain. This literature review considers patients’ understanding of, and perspectives on, MS progression to better comprehend the unmet needs of people with MS (PwMS), in order to improve treatment adherence and quality of life (QoL). METHODS: Literature searches for peer-reviewed papers concerning patient perspectives on the progression of MS and comparable conditions, published between January 2000 and January 2020, were conducted. RESULTS: Little qualitative evidence exists that examines PwMS’ perspectives on MS progression. The understanding and meaning ascribed to terms such as “disease progression” vary. Some PwMS find disease labels stigmatizing, confusing, and disconnected from reality. The lack of a clear definition of progression and discrepancies between PwMS and healthcare professional (HCP) perspectives may contribute to misunderstanding and poor communication. Patient descriptions of progression and relapses include symptoms in addition to those evaluated by standard severity and disability measures. Compared with HCPs, PwMS are still focused on relapse prevention but place higher priority on QoL and ascribe different relative importance to the causes of poor adherence to treatment plans. PwMS want to discuss progression and likely prognosis. Such communication needs to be personalized and delivered with sensitivity, at an appropriate time. Poor treatment adherence may arise from a lack of understanding and poor communication, particularly around treatment goals. The few studies that directly considered patient perspectives on the progression of comparable conditions supported and extended the perspectives of PwMS. Lack of adequate communication by HCPs was the most common theme. CONCLUSION: Patient perspectives on disease progression in MS and other chronic progressive conditions are under-investigated and under-reported. The limited evidence available highlights the importance of providing adequate information and effective HCP communication. While further studies are needed, the current evidence base offers information and insights that may help HCPs to enhance patient care, well-being, and treatment adherence. Dove 2021-01-08 /pmc/articles/PMC7802794/ /pubmed/33447018 http://dx.doi.org/10.2147/PPA.S268829 Text en © 2021 Celius et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Review Celius, Elisabeth G Thompson, Heidi Pontaga, Maija Langdon, Dawn Laroni, Alice Potra, Stanca Bharadia, Trishna Yeandle, David Shanahan, Jane van Galen, Pieter Alexandri, Nektaria Kesselring, Jürg Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives |
title | Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives |
title_full | Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives |
title_fullStr | Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives |
title_full_unstemmed | Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives |
title_short | Disease Progression in Multiple Sclerosis: A Literature Review Exploring Patient Perspectives |
title_sort | disease progression in multiple sclerosis: a literature review exploring patient perspectives |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7802794/ https://www.ncbi.nlm.nih.gov/pubmed/33447018 http://dx.doi.org/10.2147/PPA.S268829 |
work_keys_str_mv | AT celiuselisabethg diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT thompsonheidi diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT pontagamaija diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT langdondawn diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT laronialice diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT potrastanca diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT bharadiatrishna diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT yeandledavid diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT shanahanjane diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT vangalenpieter diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT alexandrinektaria diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives AT kesselringjurg diseaseprogressioninmultiplesclerosisaliteraturereviewexploringpatientperspectives |